Conditions: Erythema Rosacea
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 440
Healthy volunteers: no

Brief summary:
This study will evaluate the long-term safety and efficacy of oxymetazoline hydrogen chloride (HCL) Cream 1.0% (AGN-199201) in patients with persistent erythema associated with rosacea.

Detailed description:

Arms:
arm 1: Oxymetazoline HCL Cream 1.0% (AGN-199201) applied to the face once daily for 52 weeks.

Interventions: intervention 1: Oxymetazoline HCL Cream 1.0%
Intervention descriptions: intervention 1: Oxymetazoline HCL Cream 1.0% applied to the face once daily for 52 weeks.

Protocol document: